Mid-Atlantic Division
CHTN_BRCaProg3 - Breast Cancer Progression
TMA Map
Code Key
Tissue List
| TMA code | Diagnosis | Age | Race | Ethnicity | pT stage* | pN stage* | Estrogen Receptor† | Progesterone Receptor† | Her2 Amplification†† | Other samples from same subject |
|---|---|---|---|---|---|---|---|---|---|---|
| NB-NC-1 | Non-neoplastic breast from patients without breast carcinoma | 49 | W | Non-Hispanic | N/A | N/A | NT | NT | NT | |
| NB-NC-2 | Non-neoplastic breast from patients without breast carcinoma | 53 | W | Non-Hispanic | N/A | N/A | NT | NT | NT | |
| NB-NC-3 | Non-neoplastic breast from patients without breast carcinoma | 56 | W | Non-Hispanic | N/A | N/A | NT | NT | NT | |
| NB-NC-4 | Non-neoplastic breast from patients without breast carcinoma | 56 | W | Non-Hispanic | N/A | N/A | NT | NT | NT | |
| NB-NC-5 | Non-neoplastic breast from patients without breast carcinoma | 24 | W | Non-Hispanic | N/A | N/A | NT | NT | NT | |
| NB-NC-6 | Non-neoplastic breast from patients without breast carcinoma | 56 | W | Non-Hispanic | N/A | N/A | NT | NT | NT | |
| NB-NC-7 | Non-neoplastic breast from patients without breast carcinoma | 49 | W | Non-Hispanic | N/A | N/A | NT | NT | NT | |
| NB-C-1 | Non-neoplastic breast from breast carcinoma patients | 66 | W | Non-Hispanic | pT1c | pNX | 3+ 100% | 3+ 90% | Negative | IDC-H-1 |
| NB-C-2 | Non-neoplastic breast from breast carcinoma patients | 61 | W | Non-Hispanic | pT2 | pN1asn | 3+ 100% | 3+ 20% | Negative | IDC-H-2 |
| NB-C-3 | Non-neoplastic breast from breast carcinoma patients | 69 | W | Non-Hispanic | pT1c | PN0sn | 3+ 100% | 2+ 30% | Negative | DCIS-L-6 |
| NB-C-4 | Non-neoplastic breast from breast carcinoma patients | 74 | W | Non-Hispanic | pT1c | pNX | 3+ 100% | 3+ 90% | Negative | IDC-L-6 |
| NB-C-5 | Non-neoplastic breast from breast carcinoma patients | 53 | W | Non-Hispanic | ypT2 | pN1a | 2+ 30% | Negative | Negative | IDC-H-6, LNM-1 |
| NB-C-6 | Non-neoplastic breast from breast carcinoma patients | 86 | O | Hispanic | pT2 | pN0 | Negative | Negative | Negative | |
| NB-C-7 | Non-neoplastic breast from breast carcinoma patients | 51 | B | Non-Hispanic | pT2 | pN1a | 3+ 90% | 3+ 90% | Negative | ILC-5, LNM-7 |
| DCIS-L-1 | Ductal carcinoma in situ, intermediate grade | 54 | W | Non-Hispanic | ypTis | pN0sn | 3+ >95% | NT | NT | |
| DCIS-L-2 | Ductal carcinoma in situ, intermediate grade | 50 | W | Non-Hispanic | pTis | pNX | 3+ 100% | NT | NT | |
| DCIS-L-3 | Ductal carcinoma in situ, intermediate grade | 66 | W | Non-Hispanic | pT1c | pN0sn | 3+ >95% | NT | NT | |
| DCIS-L-4 | Ductal carcinoma in situ, intermediate grade | 78 | W | Non-Hispanic | pT1c | pNX | 3+ 100% | 3+ 100% | Negative | IDC-L-5 |
| DCIS-L-5 | Ductal carcinoma in situ, low grade | 53 | W | Non-Hispanic | mpT1mi | pNX | 3+ 100% | NT | NT | |
| DCIS-L-6 | Ductal carcinoma in situ, low gradee | 69 | W | Non-Hispanic | pT1c | pN0sn | 3+ 100% | 2+ 30% | Negative | NB-C-3 |
| DCIS-L-7 | Ductal carcinoma in situ, low grade | 77 | W | Hispanic | mpT1c | pN1asn | 3+ 100% | 3+ 90% | Negative | |
| DCIS-H-1 | Ductal carcinoma in situ, high grade | 64 | W | Non-Hispanic | pT1c | pN0sn | 3+ 100% | 1+ 5% | Negative | IDC-H-3 |
| DCIS-H-2 | Ductal carcinoma in situ, high grade | 43 | W | Non-Hispanic | pTis | pN0sn | + 28% | + 22% | NT | |
| DCIS-H-3 | Ductal carcinoma in situ, high grade | 60 | W | Non-Hispanic | pTis | pN0 | 3+ 95% | NT | NT | |
| DCIS-H-4 | Ductal carcinoma in situ, high grade | 61 | B | Non-Hispanic | pTis | pNX | 2+ 50% | NT | NT | |
| DCIS-H-5 | Ductal carcinoma in situ, high grade | 64 | W | Non-Hispanic | pT1c | pN0sn | 3+ 100% | 3+ 100% | Negative | IDC-H-5 |
| DCIS-H-6 | Ductal carcinoma in situ, high grade | 71 | W | Non-Hispanic | pTis | pN0sn | 3+ >95% | NT | NT | |
| DCIS-H-7 | Ductal carcinoma in situ, high grade | 75 | W | Non-Hispanic | pT1b | pNX | 3+ 95% | 3+ 70% | Negative | |
| IDC-L-1 | Ductal carcinoma, Grade 1 | 70 | W | Non-Hispanic | pT1b | pNX | 3+ 95% | 2-3+ 90% | Negative | |
| IDC-L-2 | Ductal carcinoma, Grade 1 | 65 | W | Non-Hispanic | pT1c | pN1asn | 3+ 95% | 3+ 95% | Negative | LNM-2 |
| IDC-L-3 | Ductal carcinoma, Grade 1 | 82 | W | Non-Hispanic | pT1c | pNX | 3+ >95% | 3+ 60% | Negative | |
| IDC-L-4 | Ductal carcinoma, Grade 1 | 57 | W | Non-Hispanic | pT1c | pN0sn | 3+ 100% | 3+ 100% | Negative | |
| IDC-L-5 | Ductal carcinoma, Grade 2 | 78 | W | Non-Hispanic | pT1c | pNX | 3+ 100% | 3+ 100% | Negative | DCIS-L-4 |
| IDC-L-6 | Ductal carcinoma, Grade 2 | 74 | W | Non-Hispanic | pT1c | pNX | 3+ 100% | 3+ 90% | Negative | NB-C-4 |
| IDC-L-7 | Ductal carcinoma, Grade 2 | 63 | W | Non-Hispanic | pT2 | pN1asn | 3+ 100% | 2+ 10% | Negative | |
| IDC-H-1 | Ductal carcinoma, Grade 3 | 66 | W | Non-Hispanic | pT1c | pNX | 3+ 100% | 3+ 90% | Negative | NB-C-1 |
| IDC-H-2 | Ductal carcinoma, Grade 3 | 61 | W | Non-Hispanic | Pt2 | pN1asn | 3+ 100% | 3+ 20% | Negative | NB-C-2 |
| IDC-H-3 | Ductal carcinoma, Grade 3 | 64 | W | Non-Hispanic | pT1c | pN0asn | 3+ 100% | 1+ 5% | Negative | DCIS-H-1 |
| IDC-H-4 | Ductal carcinoma, Grade 3 | 76 | W | Non-Hispanic | mrpT1c | pNX | 3+ 100% | 3+ 100% | Negative | |
| IDC-H-5 | Ductal carcinoma, Grade 3 | 64 | W | Non-Hispanic | pT1c | pN0sn | 3+ 100% | 3+ 100% | Negative | DCIS-H-5 |
| IDC-H-6 | Ductal carcinoma, Grade 3 | 63 | W | Non-Hispanic | ypT2 | pN1a | 2+ 30% | Negative | Negative | NB-C-5, LNM-1 |
| IDC-H-7 | Ductal carcinoma, Grade 3 | 66 | W | Non-Hispanic | ypT2 | pN0sn | Negative | Negative | Negative | |
| ILC-1 | Lobular carcinoma, Grade 2 | 71 | W | Non-Hispanic | pT4b | pN0 | 3+ 95% | 3+ 60% | Negative | |
| ILC-2 | Lobular carcinoma, Grade 2 | 60 | W | Non-Hispanic | pT2 | pN0sn | 3+ 100% | Negative | Negative | |
| ILC-3 | Lobular carcinoma, Grade 2 | 54 | B | Non-Hispanic | ypT2 | pN0 | 3+ 95% | 1-2+ 10-15% | Negative | |
| ILC-4 | Lobular carcinoma, Grade 2 | 61 | B | Non-Hispanic | pT2 | pN3a | 3+ 100% | 3+ 95% | Negative | LMN-6 |
| ILC-5 | Lobular carcinoma, Grade 2 | 51 | B | Non-Hispanic | pT2 | pN1a | 3+ 90% | 3+ 90% | Negative | NB-C-7, LNM-7 |
| ILC-6 | Lobular carcinoma, Grade 2 | 73 | B | Non-Hispanic | pT1c | pN0sn | 3+ >95% | 3+ >95% | Negative | |
| ILC-7 | Lobular carcinoma, Grade 2 | 73 | W | Non-Hispanic | pT1c | pN0sn | 3+ 95% | 3+ 80% | Negative | |
| LNM-1 | Ductal carcinoma metastatic to regional lymph node | 63 | W | Non-Hispanic | ypT2 | pN1a | 2+ 30% | Negative | Negative | NB-C-5, IDC-H-6 |
| LNM-2 | Ductal carcinoma metastatic to regional lymph node | 65 | W | Non-Hispanic | pT1c | pN1asn | 3+ 95% | 3+ 95% | Negative | IDC-L-2 |
| LNM-3 | Ductal carcinoma metastatic to regional lymph node | 54 | W | Non-Hispanic | ypT3 | pN3a | 3+ 100% | 3+ 40% | Negative | |
| LNM-4 | Ductal carcinoma metastatic to regional lymph node | 46 | W | Non-Hispanic | pT1c | pN1a | 3+ 95% | 3+ 80% | Negative | |
| LNM-5 | Ductal carcinoma with lobular features metastatic to cervical lymph node | 75 | W | Non-Hispanic | r | r | Negative | Negative | Negative | |
| LNM-6 | Ductal carcinoma metastatic to regional lymph node | 61 | B | Non-Hispanic | pT3 | pN3a | 3+ 100% | 3+ 95% | Negative | ILC-4 |
| LNM-7 | Ductal carcinoma metastatic to regional lymph node | 51 | B | Non-Hispanic | pT2 | pN1a | 3+ 90% | 3+ 90% | Negative | NB-C-7, ILC-5 |
| Race: W = white/caucasian, B = black, O = other non-white | ||||||||||
| †ER & PR: negative = <1%+, positive = ≥1%+, NT = not tested | ||||||||||
| ††Her2: negative = not amplified, positive = amplified, NT = not tested | ||||||||||